DIGIBIOMARC Trademark

Trademark Overview

On Tuesday, January 21, 2020, a trademark application was filed for DIGIBIOMARC with the United States Patent and Trademark Office. The USPTO has given the DIGIBIOMARC trademark a serial number of 88767332. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, September 16, 2025. This trademark is owned by Medable, Inc.. The DIGIBIOMARC trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
digibiomarc

General Information

Serial Number88767332
Word MarkDIGIBIOMARC
Filing DateTuesday, January 21, 2020
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, September 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 3, 2020

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, January 25, 2020
Primary Code042
First Use Anywhere DateTuesday, January 28, 2020
First Use In Commerce DateTuesday, January 28, 2020

Trademark Owner History

Party NameMedable, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPALO ALTO, CA 94301
Party NameMedable, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPALO ALTO, CA 94301

Trademark Events

Event DateEvent Description
Tuesday, March 31, 2020NON-FINAL ACTION WRITTEN
Friday, January 24, 2020NEW APPLICATION ENTERED
Saturday, January 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 24, 2020ASSIGNED TO EXAMINER
Tuesday, March 31, 2020NON-FINAL ACTION E-MAILED
Tuesday, March 31, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 10, 2020ASSIGNED TO LIE
Monday, September 14, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 14, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 3, 2020PUBLISHED FOR OPPOSITION
Tuesday, November 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 29, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 9, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, June 9, 2021SOU EXTENSION 1 FILED
Wednesday, June 9, 2021SOU EXTENSION 1 GRANTED
Friday, June 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 8, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Wednesday, September 8, 2021WITHDRAWAL OF ATTORNEY GRANTED
Tuesday, October 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 13, 2021SOU TEAS EXTENSION RECEIVED
Monday, December 13, 2021SOU EXTENSION 2 FILED
Monday, December 13, 2021SOU EXTENSION 2 GRANTED
Wednesday, December 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 23, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 23, 2022SOU EXTENSION 3 FILED
Thursday, June 23, 2022SOU EXTENSION 3 GRANTED
Saturday, June 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 28, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 28, 2022SOU EXTENSION 4 FILED
Wednesday, December 28, 2022SOU EXTENSION 4 GRANTED
Thursday, July 6, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 28, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 28, 2023SOU EXTENSION 5 FILED
Thursday, July 6, 2023SOU EXTENSION 5 GRANTED
Friday, July 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 21, 2023USE AMENDMENT FILED
Thursday, December 21, 2023TEAS STATEMENT OF USE RECEIVED
Friday, January 5, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 20, 2024STATEMENT OF USE PROCESSING COMPLETE
Friday, February 7, 2025NON-FINAL ACTION E-MAILED
Friday, February 7, 2025SU - NON-FINAL ACTION - WRITTEN
Friday, February 7, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 6, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, May 6, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, September 16, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 3, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 16, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 16, 2025SU-EXAMINER'S AMENDMENT WRITTEN
Tuesday, September 16, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 16, 2025EXAMINERS AMENDMENT E-MAILED
Tuesday, September 16, 2025EXAMINER'S AMENDMENT ENTERED

Related Keywords

digibiomarc pharmaceuticals clinical trials field information medical scientific research providing